Legal / IP

AstraZenecaBoehringer Ingelheim

Merck Loses Third Circuit Appeal as Court Upholds Medicare Drug Price Negotiations Under IRA

The U.S. Court of Appeals for the Third Circuit ruled against Merck & Co., Inc. (MSD; NYSE: MRK), rejecting the drugmaker's claim that Medicare drug price negotiations violate the First…

WuXi AppTec Wins Preliminary Injunction Against DoD 1260H Designation

WuXi AppTec Wins Preliminary Injunction Against DoD 1260H Designation

Novo Nordisk Sues Eli Lilly Over Alleged False Advertising of Zepbound and Mounjaro in GLP-1 Market

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Contact US
CARsgen Therapeutics Secures European Patent for GPC3 CAR-T Technology After Successful Opposition Proceedings
CARsgen TherapeuticsHKG: 2171

CARsgen Therapeutics Secures European Patent for GPC3 CAR-T Technology After Successful Opposition Proceedings

Harbour BioMed Wins CNIPA Validation of 'Binding Molecule' Patent Amid Dispute
Biocytogen PharmaceuticalsHarbour BioMed

Harbour BioMed Wins CNIPA Validation of ‘Binding Molecule’ Patent Amid Dispute

RemeGen Secures 1,827-Day Patent Extension for Telitacicept in China
HKG: 9995Patents

RemeGen Secures 1,827-Day Patent Extension for Telitacicept in China

Biocytogen's RenMab Platform Wins Japanese Patent, Expanding IP Portfolio
Biocytogen PharmaceuticalsHKG: 2315

Biocytogen’s RenMab Platform Wins Japanese Patent, Expanding IP Portfolio

Show More